‘Pathway preferential’ estrogens target the good and avoid the bad

New analogs selectively act on a beneficial biochemical pathway, providing a safer option for estrogen replacement therapy

via Chemical & Engineering News: Biological SCENE http://ift.tt/1TQgSVA